Farhan Y M. .2018 .Medical assistants' knowledge about preparation and administration of intravenous admixtures in the teaching hospitals of Alanbar governorate. Int. J. Pharm. Phytopharm. Res, 8(5) : 31-34.
Zenuz Taghavi,Pakdel A,Mortazavi F,Katebi F,K. F .2020 .Comparison of Changes in Urea and Electrolyte Levels in Saliva and Serum of Patients Before and after Hemodialysis. Int. J. Pharm. Phytopharm. Res, 10(1) : 142-146.
Almazroea A H,Almugheerbi S I,Alamri M A,Alloqmani M M G A,Bazarbay A A,Khoshhal B A .2019 .Prevalence of Antibiotic Use For Pediatric Acute Viral Gastroenteritis in Madinah Almunwarah, KSA. , 10(6) : 37-49.
Aghajari P,Valizadeh L,Zamanzadeh V,Ghahramanian A,Foronda C. .2017 .organizational factors affecting the implementation of culturally sensitive care in pediatric nursing in ıran: a qualitative study. Pharmacophores, 8(4) : 20-26.
Anderson BJ .2017 .Pharmacokinetics and Pharmacodynamics in the Pediatric Patient. Total Intravenous Anesthesia and Target, : .
Kern SE .2009 .Challenges in conducting clinical trials in children: approaches for improving performance. Expert Rev Clin Pharmacol, 2(6) : 609-17.
Cuzzolin L,Atzei A,Fanos V .2006 .Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf, 5(5) : 703-18.
Gore R,Chugh PK,Tripathi CD,Lhamo Y,Gautam S. Pediatric OffLabel and Unlicensed Drug Its,Implications Its .2017 .. Curr Clin Pharmacol, 12(1) : 18-25.
Santos DB,Clavenna A,Bonati M,Coelho HL .2008 .Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil. Eur J Clin Pharmacol, 64(11) : 1111-8.
Stafford RS. Regulating,Off-Label Drug RS. Regulating .2008 .- Rethinkig the Role of the FDA. N Engl J Med, 358(14) : 1427-9.
Delmas S,Bourdon O,Brion F .2016 .Prot-Labarthe S. Unlicensed and offlabel medicines and prescriptions: A descriptive analysis of the medicines formulary and of the 56,800 prescriptions in a paediatric hospital. Pediatr Dimensions, 1(1) : 46-52.
.2005 .Committee for Medicinal products for Human use (CHMP): Reflection Paper: Formulations of Choice for the Paediatric Population. , : .
Boztepe H,Ozdemir H,Karababa C .2014 .Difficulties experienced during preparation and administration of oral drugs. Turk Pediatri Ars, 49(3) : 231-7.
Polaha J,Dalton WT,Lancaster BM .2008 .Parental report of medication acceptance among youth: implications for everyday practice. South Med, 101(11) : 1106-12.
Corny J,Bailey B,Lebel D,Bussieres JF .2016 .Unlicensed and off-label drug use in paediatrics in a mother-child tertiary care hospital. Paediatr Child Health, 21(2) : 83-7.
Ivanovska V,Rademaker CMA,van Dijk L,Mantel-Teeuwisse AK .2014 .Pediatric Drug Formulations: A Review of Challenges and Progress. Pediatrics, 134(2) : 361-72.
Costa H,Costa TX,Martins RR,Oliveira AG .2018 .Use of off-label and unlicensed medicines in neonatal intensive care. PLoS One, 13(9) : e0204427.
Robinson CA,Siu A,Meyers R,Lee BH,Cash J .2014 .Standard dose development for medications commonly used in the neonatal intensive care unit. J Pediatr Pharmacol Ther, 19(2) : 118-26.
Gerrard S,Walsh J,Bowers N,Salunke S,Hershenson S. .2019 .Innovations in Pediatric Drug Formulations and Administration Technologies for Low Resource Settings. , 11(518) : 1-11.
Langerová P,Vrtal J,Urbánek K. .2014 .Incidence of unlicensed and offlabel prescription in children. Italian Journal of Pediatrics, 40(1) : 12.
t Jong GW,van der Linden PD,Bakker EM,van der Lely N,Eland IA,Stricker BH .2002 .Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands. Eur J Clin Pharmacol, 58(4) : 293-7.
Conroy S. .2011 .Association between licence status and medication errors. Arch Dis Child, 96(3) : 305-6.
Lee JL,Redzuan AM,Shah NM .2013 .Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia. Int J Clin Pharm, 35(6) : 1025-9.
Batchelor HK,Marriott JF .2015 .Formulations for children: problems and solutions. Br J Clin Pharmacol, 79(3) : 405-18.